Ribonexus

New oncology therapies to deliver drugs that restore sensitivity to current targeted therapies

Total raised

€2.0M

€2,000,000

Funding rounds

Investors

distinct backers

Active since

2022-04

latest 2022-04

Funding by year

EUR raised per year

High confidence

Raise-next likelihood11

base rate 30% for Other

Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2022-04-12	Other	€2.0M	Bpifrance	View deal →

same sector or country